226 related articles for article (PubMed ID: 6241649)
1. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic mice.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):731-5. PubMed ID: 6241648
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
Neu HC; Chin NX; Labthavikul P; Saha G
Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
5. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Piccolomini R; Allocati N; Catamo G
Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
Shah PM; Ottnad-Walz M; Stille W
Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of gram negative bacteria in midstream bladder urine and their sensitivity to quinoline derivatives.
Esposito S; Galante D; Pennucci C; Barba D
Microbiologica; 1985 Jul; 8(3):269-76. PubMed ID: 3162081
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
Zeiler HJ; Petersen U; Gau W; Ploschke HJ
Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
Shungu DL; Tutlane VK; Weinberg E; Gadebusch HH
Chemotherapy; 1985; 31(2):112-8. PubMed ID: 3157551
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of norfloxacin.
Norrby SR; Jonsson M
Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of E-3604, a new 6-fluoroquinolone, on clinical isolates.
Xicota MA; Coll R; Esteve M; Moros M; Parés J
Drugs Exp Clin Res; 1987; 13(3):133-6. PubMed ID: 3622242
[TBL] [Abstract][Full Text] [Related]
14. Post-antibiotic effect of three quinolones against gram negative isolates from urine.
Alados JC; Gutierrez J; Garcia F; Liebana J; Piedrola G
Med Lab Sci; 1990 Oct; 47(4):272-7. PubMed ID: 2283929
[TBL] [Abstract][Full Text] [Related]
15. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
16. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
Peddie BA
N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
[No Abstract] [Full Text] [Related]
17. Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.
Darrell RW; Modak SM; Fox CL
Trans Am Ophthalmol Soc; 1984; 82():75-91. PubMed ID: 6242083
[TBL] [Abstract][Full Text] [Related]
18. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
[TBL] [Abstract][Full Text] [Related]
19. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]